About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?

Katharine Louise Lewis; Chan Yoon Cheah

doi:10.1080/17474086.2022.2140138

About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	959-962
Number of pages	4
Journal	Expert Review of Hematology
Volume	15
Issue number	11
DOIs	https://doi.org/10.1080/17474086.2022.2140138
Publication status	Published - 2022

Access to Document

10.1080/17474086.2022.2140138

Cite this

@article{1ed38fa8041e41b1a2cc3a6941b9caed,

title = "About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?",

keywords = "Diffuse large B-cell lymphoma, central nervous system relapse, methotrexate, prophylaxis, CNS PROPHYLAXIS, HIGH-RISK, INTRAVENOUS METHOTREXATE, RITUXIMAB, RELAPSE, CHOP, CHEMOTHERAPY, MULTICENTER, TESTIS, IMPACT",

author = "Lewis, {Katharine Louise} and Cheah, {Chan Yoon}",

year = "2022",

doi = "10.1080/17474086.2022.2140138",

language = "English",

volume = "15",

pages = "959--962",

journal = "Expert Review of Hematology",

issn = "1747-4086",

publisher = "Expert Reviews",

number = "11",

}

TY - JOUR

T1 - About time

T2 - why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?

AU - Lewis, Katharine Louise

AU - Cheah, Chan Yoon

PY - 2022

Y1 - 2022

KW - Diffuse large B-cell lymphoma

KW - central nervous system relapse

KW - methotrexate

KW - prophylaxis

KW - CNS PROPHYLAXIS

KW - HIGH-RISK

KW - INTRAVENOUS METHOTREXATE

KW - RITUXIMAB

KW - RELAPSE

KW - CHOP

KW - CHEMOTHERAPY

KW - MULTICENTER

KW - TESTIS

KW - IMPACT

UR - http://www.scopus.com/inward/record.url?scp=85141023798&partnerID=8YFLogxK

U2 - 10.1080/17474086.2022.2140138

DO - 10.1080/17474086.2022.2140138

M3 - Editorial

C2 - 36278876

SN - 1747-4086

VL - 15

SP - 959

EP - 962

JO - Expert Review of Hematology

JF - Expert Review of Hematology

IS - 11

ER -

About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?

Access to Document

Other files and links

Cite this